TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2024	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023
Cash & Equivalents	3.62	12.66	4.91	3.67	1.54
Cash & Short-Term Investments	3.62	12.66	4.91	3.67	1.54
Cash Growth	-71.40%	157.84%	33.94%	138.76%	-86.97%
Other Receivables	0.5	-	-	-	-
Total Trade Receivables	0.5	-	-	-	-
Other Current Assets	0.5	6.95	0.62	0.49	1.74
Total Current Assets	4.62	19.61	5.53	4.16	3.27
Net Property, Plant & Equipment	0.69	0.32	0.67	0.2	0.71
Other Intangible Assets	11.28	-	-	-	-
Goodwill	10.74	-	-	-	-
Other Long-Term Assets	0.03	0.03	-	-	-
Total Assets	27.35	19.97	6.2	4.36	3.98
Accounts Payable	5.52	5.17	2.26	3.44	3.08
Short-Term Debt	0.2	-	-	-	-
Current Portion of Leases	0.2	0.16	-	0.02	-
Other Current Liabilities	-	-	-	0.14	-
Total Current Liabilities	5.92	5.33	2.26	3.6	3.08
Long-Term Debt	-	-	-	2.32	-
Other Long-Term Liabilities	0.2	-	0.19	-	0.17
Total Long-Term Liabilities	0.2	-	0.19	2.32	0.17
Total Liabilities	6.42	5.37	2.45	5.92	3.25
Preferred Stock	-	-	10.25	0.02	10.65
Common Stock	0.06	0.04	0	0.01	0
Additional Paid-in Capital	161.78	125.4	153.36	86.89	141.44
Accumulated Other Comprehensive Income	-	-	0.02	-	0.02
Retained Earnings	-141.19	-111.13	-159.88	-88.48	-151.38
Total Common Shareholders' Equity	20.65	14.32	3.76	-1.56	0.73
Shareholders' Equity	20.93	14.59	3.76	-1.56	0.73
Total Liabilities & Equity	27.35	19.97	6.2	4.36	3.98
Total Debt	0.4	0.16	0	2.34	0
Net Cash (Debt)	3.22	12.5	4.91	1.32	1.54
Net Cash Growth	-74.21%	154.58%	271.88%	-14.00%	-86.97%
Net Cash Per Share	0.07	0.67	6.52	1.75	33.16
Book Value	20.65	14.32	3.76	-1.56	0.73
Book Value Per Share	0.43	0.77	4.99	-2.07	15.79
Tangible Book Value	-1.36	14.32	3.76	-1.56	0.73
Tangible Book Value Per Share	-0.03	0.77	4.99	-2.07	15.79

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q